Cite
HARVARD Citation
Lanzoni, G. et al. (2021). Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial. Stem cells translational medicine. pp. 660-673. [Online].